Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites.
Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites.
复制标题
DOI:
10.1128/spectrum.00797-22
复制
发表时间:
2022-06-29
影响因子:
3.7
通讯作者:
Dean D
中科院分区:
文献类型:
--
作者:
Ham RE;Smothers AR;Che R;Sell KJ;Peng CA;Dean D
SARS-CoV-2 variants of concern (VOCs) continue to pose a public health threat which necessitates a real-time monitoring strategy to complement whole genome sequencing. Thus, we investigated the efficacy of competitive probe RT-qPCR assays for six mutation sites identified in SARS-CoV-2 VOCs and, after validating the assays with synthetic RNA, performed these assays on positive saliva samples. When compared with whole genome sequence results, the SΔ69-70 and ORF1aΔ3675-3677 assays demonstrated 93.60 and 68.00% accuracy, respectively. The SNP assays (K417T, E484K, E484Q, L452R) demonstrated 99.20, 96.40, 99.60, and 96.80% accuracies, respectively. Lastly, we screened 345 positive saliva samples from 7 to 22 December 2021 using Omicron-specific mutation assays and were able to quickly identify rapid spread of Omicron in Upstate South Carolina. Our workflow demonstrates a novel approach for low-cost, real-time population screening of VOCs. IMPORTANCE SARS-CoV-2 variants of concern and their many sublineages can be characterized by mutations present within their genetic sequences. These mutations can provide selective advantages such as increased transmissibility and antibody evasion, which influences public health recommendations such as mask mandates, quarantine requirements, and treatment regimens. Our RT-qPCR workflow allows for strain identification of SARS-CoV-2 positive saliva samples by targeting common mutation sites shared between variants of concern and detecting single nucleotides present at the targeted location. This differential diagnostic system can quickly and effectively identify a wide array of SARS-CoV-2 strains, which can provide more informed public health surveillance strategies in the future.
登录
查看更多内容
影响因子:
9.4
作者:
Griesemer SB;Van Slyke G;Ehrbar D;Strle K;Yildirim T;Centurioni DA;Walsh AC;Chang AK;Waxman MJ;St George K
通讯作者:
St George K
影响因子:
8.8
作者:
Meng B;Kemp SA;Papa G;Datir R;Ferreira IATM;Marelli S;Harvey WT;Lytras S;Mohamed A;Gallo G;Thakur N;Collier DA;Mlcochova P;COVID-19 Genomics UK (COG-UK) Consortium;Duncan LM;Carabelli AM;Kenyon JC;Lever AM;De Marco A;Saliba C;Culap K;Cameroni E;Matheson NJ;Piccoli L;Corti D;James LC;Robertson DL;Bailey D;Gupta RK
通讯作者:
Gupta RK
影响因子:
14.2
作者:
Pasomsub, E.;Watcharananan, S. P.;Phuphuakrat, A.
通讯作者:
Phuphuakrat, A.
影响因子:
4.5
作者:
Crawford DC;Williams SM
通讯作者:
Williams SM
影响因子:
5.3
作者:
Duchene, Sebastian;Featherstone, Leo;Baele, Guy
通讯作者:
Baele, Guy